9NJ-29258-64210
3 vaccinations
1 coded response
28 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 180 / PA
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-20
Registered in v-safe
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-28
- 2021-01-02
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-09
- 2021-01-13
- 2021-01-16
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-04-09
- 2021-07-08
-
2021-09-25
Dose 3 — Pfizer-BioNTech
- 2021-09-28
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
-
2021-12-25
Survey response — 3 months, dose 3MedDRA: Cough, Laryngitis — Feeling: FairFree text: Cough, laryngitisMedDRA releases: 2024-11 · check-in free text available
- 2022-03-26
- 2022-09-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 3
Symptoms: Cough, laryngitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release